[HTML][HTML] MALDI-TOF MS in a medical mycology laboratory: on stage and backstage

…, M Cornet, A Hennebique, T Rasamoelina, Y Caspar… - Microorganisms, 2021 - mdpi.com
The implementation of MALDI-TOF MS in medical microbiology laboratories has revolutionized
practices and significantly reduced turnaround times of identification processes. However…

[HTML][HTML] New therapeutic approaches for treatment of tularaemia: a review

S Boisset, Y Caspar, V Sutera… - Frontiers in cellular and …, 2014 - frontiersin.org
Antibiotic treatment of tularaemia is based on a few drugs, including the fluoroquinolones (eg,
ciprofloxacin), the tetracyclines (eg, doxycycline), and the aminoglycosides (streptomycin …

[HTML][HTML] Francisella tularensis Susceptibility to Antibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models

Y Caspar, M Maurin - Frontiers in cellular and infection microbiology, 2017 - frontiersin.org
The antibiotic classes that are recommended for tularaemia treatment are the aminoglycosides,
the fluoroquinolones and the tetracyclines. However, cure rates vary between 60 and 100…

Assessment of respiratory bacterial coinfections among severe acute respiratory syndrome coronavirus 2-positive patients hospitalized in intensive care units using …

…, AG Ranc, S Boisset, Y Caspar… - Open forum …, 2020 - academic.oup.com
Background Approximately 15% of patients infected by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) present with severe forms of the disease and require …

[HTML][HTML] Evaluation of Rapid Sepsityper® protocol and specific MBT-Sepsityper module (Bruker Daltonics) for the rapid diagnosis of bacteremia and fungemia by …

…, T Girard, C Landelle, M Maurin, Y Caspar - Annals of Clinical …, 2020 - Springer
During bloodstream infections, rapid adaptation of empirical treatment according to the
microorganism identified is essential to decrease mortality. The aim of the present study was to …

[HTML][HTML] Bacterial behavior in human blood reveals complement evaders with some persister-like features

S Pont, N Fraikin, Y Caspar, L Van Melderen… - PLoS …, 2020 - journals.plos.org
Bacterial bloodstream infections (BSI) are a major health concern and can cause up to 40%
mortality. Pseudomonas aeruginosa BSI is often of nosocomial origin and is associated with …

[HTML][HTML] Case Studies and Literature Review of Francisella tularensis–Related Prosthetic Joint Infection

…, S Boisset, I Pelloux, Y Caspar - Emerging Infectious …, 2023 - ncbi.nlm.nih.gov
Tularemia is a zoonotic infection caused by Francisella tularensis. Its most typical manifestations
in humans are ulceroglandular and glandular; infections in prosthetic joints are rare. …

[HTML][HTML] mcr-1 colistin resistance in ESBL-producing Klebsiella pneumoniae, France

Y Caspar, M Maillet, P Pavese, G Francony… - Emerging infectious …, 2017 - ncbi.nlm.nih.gov
We report intestinal carriage of an extended-spectrum β-lactamase− producing Klebsiella
pneumoniae strain with high-level resistance to colistin (MIC 24 mg/L) in a patient in France …

Evaluation of the QIAstat-Dx Meningitis/Encephalitis Panel, a multiplex PCR platform for the detection of community-acquired meningoencephalitis

…, M Rey, S Johnson, J Pareja, Y Caspar - Journal of Clinical …, 2023 - Am Soc Microbiol
Rapid identification of the causative pathogens of central nervous system infections is
essential for providing appropriate management and improving patient outcomes. The …

[HTML][HTML] Phylogeography and Genetic Diversity of Francisella tularensis subsp. holarctica in France (1947–2018)

M Kevin, G Girault, Y Caspar, MA Cherfa… - Frontiers in …, 2020 - frontiersin.org
In France, tularemia is caused by Francisella tularensis subsp. holarctica and is a sporadic
disease affecting mainly wildlife animals and humans. F. tularensis species presents low …